Proton pump inhibitors and the risk for gastric cancer: possible confounding by serum vitamin B

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

1. Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study.BMJ (Clinical research ed.) · 2019
   Article
2. Characteristics and predictors of gastric cancer afterWorld journal of gastroenterology · 2018
   Review

Corrections and comments

• Commented on by
  Proton pump inhibitors and risk of gastric cancer in a case-control study.2019
• Comment on
  Long-term proton pump inhibitors and risk of gastric cancer development after treatment for2018

Authors and funding

4 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as